STML
Stemline Therapeutics IncstockNASDAQ
InactiveJun 9, 2020 4:00:00 PM EDT
11.83USD-1.417%(-0.17)
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
HQ
NY, USA
Nov 4, 2026
Oct 22, 2026
STML Profile
Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.
STML Performance
| Period | Price | Date | Change |
|---|